Psychiatric manifestations of premenstrual syndrome: literature review
Keywords:
late luteous phase, premenstrual syndrome, menstrual cycleAbstract
The objective of this paper is to find out which are the main criteria and instruments used for the diagnosis of Psychiatric Manifestations of Premenstrual Syndrome. We emphasize the importance of diferential diagnosis between psychiatric problems that have their symptoms increased during the late luteous phase of the menstrual cycle and the psychiatric manifestations due to Premenstrual Syndrome. Several studies suggest a limit score in psychiatric scales to distinguish both. The most used scales are: Beck Depression Inventory, Hamilton Anxiety Rating Scale, Hopkins Symptom Checklist-90.
The methodology used was the analysis of publication about this subject from 1992 to 1995. The conclusion is that there are several instruments used to determine the diagnosis in question, hut there is no consensus about an ideal one. The GnRH agonists, as well as fluoxetine, alprazolam and Beta-endorphins, are being considered therapeutical.
Downloads
References
CHENIAUX JR., E., LAKS, J., CHALUB, M. Síndrome pré-menstrual: possíveis relações com os distúrbios afetivos. Jornal Brasileiro de Psiquiatria, Rio de Janeiro, v.43, n.5, parte 1, p.271-280, 1994.
CHRISTENSEN, A.P., BOARD, B.J., OEI, T.P. A psychosocial profile of women with premenstrual dysphoria. Journal of Affective Disorders, Amsterdan, v.25, n.4, p.251-259, 1992.
CHUONG, c.J., HSI, B.P., GIBBONS, W.E. Periovulatory beta-endorphin levels in premenstrual syndrome. Obstetrics Ginecologv, New York, v.83 (5 pt l), 1994.
CLASSIFICAÇÃO internacional de doenças. IO. ed. Porto Alegre: Sagra, 1994. 104p.
DIAGNOSTIC and statistical manual of mental disorders. 3.ed. DSM m-R., Washington, DC: American Psychiatric Association, 1987.
ENDICOTT, J. The menstrual cycle and mood disorders. Journal of Affective Disorders, Amsterdan, v.29, n.213, p.193-200, 1993.
FREEMAN, E.w., SONDHEIMER, s.J., RICKELS, K., ALBERT, J. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comosbidity of depression: a pilor study. Journal of Clinicai Psychiatry, Memphis, v.54, n.5, p. 192-195, 1993.
HALBE, H. Tratado de ginecologia. São Paulo : Roca, 1987. v.2.
HELVACIOGLU, A., YEOMAN, R.R., HAZELRON, J.M., AKSEL, S. Premenstrual syndrome and related hormonal changes: long-acting gonadotropin-releasing hormone agonist treatment. Journal of Reproductive Medicine, Chicago, v.38, n.11, p.864-870, 1993.
HURT, S.W., SCHNURR, P.P. Late lutealphase dysphiric disorder (letter). P.sychosomatici Medicine, Baltimore, v.54, n.6, p.723-728, 1992.
MARTINEZ-JORDAN, N. Relation between psyehological symptoms and gynecological, hormonal and perimenopausal disorders. Actas Luso Espanhola de Neurologia Psiquiatria e Ciências Afines, Madrid, v.21, n.4, p.31,42, 1993.
McLEOD, D.R., FOSTER, G.v., HOEHN-SARIC, R., SUIKIS, s.D., KIPSLEY, P.A. Family history of alcoholism in women with generalized anxiety disorder Who have premenstrual syndrome: patient reports of premenstrual alcohol consumption and symptoms of anxiety. A Icoholism ClinicaI and Experimental Research, Baltimore, v. 18, n.3, p.664-670, 1994.
McLEOD, D.R., HOEHN-SARIC, R., FOSTER, G.v., HIPSLEY, P.A. The influence of premenstrual syndrome on ratings of anxiety in women with generalized anxiety disorder. Acta Psyschiatica Scandinavica, Copenhagen, v.88, n.4, p.248-251, 1993.
MEDEN-URTOUEC, H., VUJIE, D. Bronocriptine (Bromergon, Lek) in the management of premenstrual syndrome. Clinical and Experimental Obstetric and Gynecologv, Padova, v.19, n.4, p.242-248, 1992.
